MEDTECH INNOVATION PARTNER
SS Innovations International Inc. is a medical technology company focused on advancing robotic surgical care through innovation that is advanced, accessible, and affordable. Founded by Dr. Sudhir Srivastava, a globally acclaimed pioneer in robotic cardiac surgery, the company is driven by a mission to expand access to advanced surgical technology and improve patient outcomes.
Headquartered in Gurugram, Haryana, India, SS Innovations has developed its flagship product, the SSI Mantra surgical robotic system, a modular, surgeon-centric robotic platform designed to support multi-specialty soft-tissue surgeries including cardiac, urology, gynecology and general surgery. The system emphasizes precision, ergonomic comfort and flexible configuration, enabling efficient adoption across diverse healthcare settings.
To extend the reach of robotic surgery beyond conventional hospital infrastructure, SS Innovations has introduced SSI MantraM, a mobile tele-robotic surgery unit designed to deliver advanced robotic surgical capabilities to remote and underserved locations. Often described as telesurgery on wheels, MantraM enables real-time collaboration and remote surgical intervention, supporting access to expert care across geographies.
The company has also developed SSI MantrAsana, an ergonomic telesurgeon console designed to allow surgeons to operate the SSI Mantra system from remote locations such as their home or office. MantrAsana supports remote surgical control and mentoring, enabling the expansion of tele-robotic surgery and continuity of care across distances.
Since its inception, over 180 SSI Mantra systems have been deployed, particularly in Tier II and Tier III cities where imported robotic platforms were previously unaffordable. To date, more than 8,000 surgeries, including complex cardiac procedures, have been successfully performed using these indigenous systems, positively transforming thousands of lives.
SS Innovations continues to focus on research, clinical validation and surgeon training to support the safe and effective adoption of robotic surgery. The company is publicly listed on the NASDAQ under the ticker symbol SSII, reflecting its growing global presence and long-term commitment to innovation in the medical technology sector.
